Government Signs 2billion Deal For 100-Million Doses of COVID Vaccine Never Tested For Safety

US Government Signs $2-Billion Deal for 100-Million
Doses of COVID Vaccine Never Tested for Safety

needtoknow.news/2020/07/us-government-signs-2-billion-deal-for-100-million-doses-of-covid-vaccine-never-tested-
for-safety
Pixabay
The US signed a $1.95 billion agreement with pharma giant Pfizer and Germany’s
BioNTech for 100-million doses of their experimental COVID-19 vaccine that Americans
will be told to accept early next year. RNA vaccines have never received regulatory
approval because they never have been tested for safety of efficacy. A vaccine trial involving
30,000 healthy volunteers may happen later this month – but the money has been
approved anyway as though those making the deal already know the tests will not be
allowed to fail – no matter the results. The government also signed other experimental
vaccine deals, including a $1.6-billion contract with Novavax for 100-million doses, $1.2-
billion for AstraZeneca’s new vaccine, $456-million for Johnson & Johnson’s new vaccine;
$486-million for Moderna’s experimental vaccine; and $6-million for Emergent
Biosolutions’ vaccine.
An estimated 30% of Americans have said they will reject the vaccine. Trump said he will
accept the vaccine. He mentioned that he knew several people who died from coronavirus,
but he also admitted they were older and had other potentially fatal health problems.
Trump said he “almost” prefers therapeutic drugs over vaccines but stands on his pledge to
use the military to force the acceptance of vaccines as soon as they are available. -GEG
Watch Video At: https://youtu.be/kzhh_QqHVXU
The United States on on Tuesday signed a $1.95 billion agreement with US pharma giant
Pfizer and Germany’s BioNTech for 100 million doses of their experimental COVID-19
vaccine, part of an aggressive push to start immunizing Americans early next year.
It is the biggest deal to date under Operation Warp Speed, intended to accelerate the
development, manufacturing, and distribution of coronavirus vaccines, therapeutics, and
diagnostics.
Pfizer and BioNTech, which are developing the drug together, said in statements that the
American people would receive the future vaccine “for free” in line with the Trump
administration’s pledge.
Under the agreement, the US government has placed an initial order for 100 million doses
to be delivered if regulatory approval is granted.
1/3
The US government also has an option to purchase as many as 500 million additional
doses from the two firms.
BioNTech and Pfizer have narrowed their vaccine candidates down to two frontrunners
and are waiting for the green light to begin a mass trial involving 30,000 healthy
volunteers, which may happen later this month.
If the studies are successful, they expect to receive some form of emergency approval as
early as October 2020.
Earlier this month, they announced that early results showed their lead candidate
produced neutralizing antibodies in humans at or above the levels observed in recovered
COVID-19 patients.
This was accomplished with relatively low doses and caused side effects that were mild to
moderate but transient, which is considered normal.
“We are assembling a portfolio of vaccines to increase the odds that the American people
will have at least one safe, effective vaccine as soon as the end of this year,” said health
secretary Alex Azar of the deal.
“We are honored to be a part of this effort to provide Americans access to protection from
this deadly virus,” added Albert Bourla, chairman and CEO of Pfizer.
– Vaccine race –
Labs around the world are racing to produce a vaccine to help end the worst health crisis in
over a century.
More than 200 candidate vaccines are currently being developed with roughly two dozen at
the stage of clinical trials with human volunteers.
Earlier this month, the US signed a $1.6 billion deal with Novavax for 100 million doses.
In May, the government announced up to $1.2 billion for AstraZeneca’s candidate vaccine,
developed in conjunction with the University of Oxford.
The US has also announced $456 million for Johnson & Johnson’s vaccine candidate; $486
million for Moderna’s; and $628 million for Emergent Biosolutions.
The government is likewise investing in manufacturing capacity at its own risk, and
spending hundreds of millions in companies that produce syringes, vials and medical glass-
coated plastic containers.
– RNA vaccine –
2/3
The Pfizer-BioNTech vaccine method relies on using messenger RNA, genetic code from
the SARS-CoV-2 that slips into human cells to produce a synthetic form of the virus’ spike
protein.
3/3

Government Signs 2billion Deal For 100-Million Doses of COVID Vaccine Never Tested For Safety

Uploaded by

Copyright:

Available Formats

Government Signs 2billion Deal For 100-Million Doses of COVID Vaccine Never Tested For Safety

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Government Signs 2billion Deal For 100-Million Doses of COVID Vaccine Never Tested For Safety

Uploaded by

Copyright:

Available Formats

US Government Signs $2-Billion Deal for 100-Million

Doses of COVID Vaccine Never Tested for Safety

Watch Video At: https://youtu.be/kzhh_QqHVXU

You might also like